UPDATE : Monday, September 16, 2019
Immunotherapies Opdivo, Keytruda score high in real setting
Immunotherapies Opdivo Inj. and Keytruda Inj. showed excellent efficacy and...
by Kim Eun-young  |  2019-09-10 12:49
Canada OKs Celltrion's biosimilar
Celltrion said that Health Canada has given the go-ahead for Herzuma (Ingre...
by Lee Han-soo  |  2019-09-10 12:48
Samsung Bioepis launches Enbrel biosimilar in Brazil
Samsung Bioepis said that it has received sales approval for Brenzys, an En...
by Lee Han-soo  |  2019-09-10 12:21
Method found to reduce adverse effects of bowel disease treatments
Severance Hospital researchers have found a new way to reduce the adverse e...
by Lee Han-soo  |  2019-09-09 17:59
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’
Bayer said that it has presented two real-world research results that have ...
by Lee Han-soo  |  2019-09-09 16:54
Invossa victims furious at government, Kolon for ‘doing nothing’
“We’ve never heard when and how they would do a long-term follow-up. Kolon ...
by Jeong Sae-im  |  2019-09-09 15:47
Hanmi to unveil investigator-led P2 progress for cancer treatment
Hanmi said that MD Anderson Cancer Center has presented the development of ...
by Lee Han-soo  |  2019-09-09 15:47
‘Micro blood vessel’s density can increase diagnostic accuracy of glaucoma’
A research team at Asan Medical Center (AMC) has found that in addition to ...
by Lee Han-soo  |  2019-09-09 14:18
Novo Nordisk's Ryzodeg leads Korean mixed insulin market
Novo Nordisk Korea said Monday that Ryzodeg, the company's soluble insu...
by Lee Han-soo  |  2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019
The highlight of the upcoming ESMO 2019, a cancer meeting in Europe, will b...
by Kim Yun-mi  |  2019-09-09 11:56
Ildong to sell GSK’s influenza treatment
Ildong Pharmaceutical said that it would exclusively promote and market GSK...
by Lee Han-soo  |  2019-09-06 17:02
Nobel laureate Honjo anticipates best combo in immunotherapies
Professor Tasuku Honjo of Kyoto University said he was expecting a good out...
by Jeong Sae-im  |  2019-09-06 16:29
Philadelphia Science Center to help Korean diagnostic firms enter US market
Korea In Vitro Diagnostic Association (KIVDA) said that it would cooperate ...
by Lee Han-soo  |  2019-09-06 16:26
‘No antibiotic works for patients with multidrug-resistant infections’
The number of patients with multidrug resistant bacteria such as Carbapenem...
by Kim Yun-mi  |  2019-09-06 15:11
Yuhan to expand biz scope to central nervous system disease
“We will broaden open innovation toward the academic sector and expand our ...
by Jeong Sae-im  |  2019-09-06 14:56
Drug safety institute conducts APEC program
The Korea Institute of Drug Safety and Risk Management (KIDS) said that it ...
by Lee Han-soo  |  2019-09-06 14:53
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan
Seoul Pharmaceutical said that it would export $4.9 million worth of its or...
by Lee Han-soo  |  2019-09-05 17:04
Lilly’s migraine treatment Emgality lands in Korea
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: gal...
by Lee Hye-seon  |  2019-09-05 16:24
SNUBH researchers find new disease that causes acute dizziness
A Seoul National University Bundang Hospital (SNUBH) research team has disc...
by Lee Han-soo  |  2019-09-05 16:21
Korean doctors categorize 12 cases to refuse treatment
The local medical community’s voice is growing for doctors’ rights to refus...
by Song Soo-youn  |  2019-09-05 16:19
Back to Top